No CrossRef data available.
Article contents
Transcatheter patent ductus arteriosus closure in premature infants requiring high-frequency ventilation
Published online by Cambridge University Press: 11 April 2024
Abstract
Transcatheter closure has become a common treatment method for patent ductus arteriosus in premature infants at many centres; however, many remain uncertain about the ability to perform the procedure in the catheterisation laboratory for infants requiring high-frequency ventilation. This study presents our centre’s experience following the implementation of neonatal ventilatory guidelines, which resulted in 100% procedural success without any procedural or respiratory adverse events.
Keywords
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press
References
Gentle, SJ, Travers, CP, Clark, M, Carlo, WA, Ambalavanan, N. Patent ductus arteriosus and development of bronchopulmonary dysplasia-associated pulmonary hypertension. Am J Respir Crit Care Med 2023; 207: 921–928.CrossRefGoogle ScholarPubMed
Noori, S, McCoy, M, Friedlich, P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123: e138–e144.CrossRefGoogle ScholarPubMed
Sathanandam, S, Gutfinger, D, O’Brien, L, et al. Amplatzer piccolo occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients >700 grams. Catheter Cardiovasc Interv 2020; 96: 1266–1276.CrossRefGoogle ScholarPubMed